Counting the costs of overweight and obesity: modeling clinical and cost outcomes
- 23 January 2006
- journal article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 22 (3) , 575-586
- https://doi.org/10.1185/030079906x96227
Abstract
Objective: To quantify changes in clinical and cost outcomes associated with increasing levels of body mass index (BMI) in a US setting. Research methods and procedures: A semi-Markov model was developed to project and compare life expectancy (LE), quality-adjusted life expectancy (QALE) and direct medical costs associated with distinct levels of BMI in simulated adult cohorts over a lifetime horizon. Cohort definitions included age (20–65 years), gender, race, and BMI (24–45 kg m−2). Cohorts were exclusively male or female and either Caucasian or African-American. Mortality rates were adjusted according to these factors using published data. BMI progression over time was modeled. BMI-dependent US direct medical costs were derived from published sources and inflated to year 2004 values. A third party reimbursement perspective was taken. QALE and costs were discounted at 3% per annum. Results: In young Caucasian cohorts LE decreased as BMI increased. However, in older Caucasian cohorts the BMI associated with greatest longevity was higher than 25 kg m−2. A similar pattern was observed in young adult African-American cohorts. A survival paradox was projected in older African-American cohorts, with some BMI levels in the obese category associated with greatest longevity. QALE in all four race/gender cohorts followed similar patterns to LE. Sensitivity analyses demonstrated that simulating BMI progression over time had an important impact on results. Direct costs in all four cohorts increased with BMI, with a few exceptions. Conclusions: Optimal BMI, in terms of longevity, varied between race/gender cohorts and within these cohorts, according to age, contributing to the debate over what BMI level or distribution should be considered ideal in terms of mortality risk. Simulating BMI progression over time had a substantial impact on health outcomes and should be modeled in future health economic analyses of overweight and obesity.Keywords
This publication has 22 references indexed in Scilit:
- Obesity and the Use of Health Care ServicesObesity Research, 2005
- Health Services Use and Health Care Costs of Obese and Nonobese IndividualsArchives of internal medicine (1960), 2004
- Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002JAMA, 2004
- Global Prevalence of DiabetesDiabetes Care, 2004
- Hierarchical linear models for the development of growth curves: an example with body mass index in overweight/obese adultsStatistics in Medicine, 2003
- Prevalence and Trends in Obesity Among US Adults, 1999-2000JAMA, 2002
- Handling Uncertainty in Cost-Effectiveness ModelsPharmacoEconomics, 2000
- Overweight and obesity in the United States: prevalence and trends, 1960–1994International Journal of Obesity, 1997
- Primer on Medical Decision Analysis: Part 5—Working with Markov ProcessesMedical Decision Making, 1997
- Markov Models in Medical Decision MakingMedical Decision Making, 1993